These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4182112)

  • 41. [On clinical use of high single doses of sarcolysine and exdoxan (cyclophosphan)].
    Garin AM; Astrakhan VI; Bychkov MB; Larionov LF; Perevodchikova NI
    Vopr Onkol; 1965; 11(10):3-9. PubMed ID: 5333877
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.
    Bergsagel DE; Robertson GL; Hasselback R
    Can Med Assoc J; 1968 Mar; 98(11):532-8. PubMed ID: 5643297
    [No Abstract]   [Full Text] [Related]  

  • 43. Complications of treatment of small cell carcinoma of the lung.
    Abeloff MD; Klastersky J; Drings PD; Eagan RT; Greco FA; Holsti L; Mattson K; Postmus PE
    Cancer Treat Rep; 1983 Jan; 67(1):21-6. PubMed ID: 6311410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Incidence and degree of intolerance and toxic effect of cytostatics in the treatment of lung cancer].
    Traczyk K; Zych D; Decker E; Radziukiewicz-Byszewska D; Krychniak W; Marzinek M; Pecyna-Sielewicz J; Ponahajba A; Siekierzyńska A; Słupek A
    Pneumonol Pol; 1980; 48(12):831-40. PubMed ID: 7220354
    [No Abstract]   [Full Text] [Related]  

  • 45. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
    Rudolf Z; Plesnicar S
    Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
    Eagan RT; Frytak S; Ingle JN; Creagan ET; Nichols WC; Kvols LK
    Cancer Treat Rep; 1980; 64(8-9):925-8. PubMed ID: 7192602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of lung neoplasms with massive single doses of cyclophosphane in combination with the protector cystaphos].
    Batinov IN; Trakhtenberg AK; Trubnikova EN; Sukhin GM
    Vopr Onkol; 1971 Dec; 17(12):83-4. PubMed ID: 5144166
    [No Abstract]   [Full Text] [Related]  

  • 48. [Drug induced pulmonary disease. Diffuse interstitial pneumonitis during chemoradiotherapy for small cell carcinoma of the lung. Two cases (author's transl)].
    Riou R; Duvillard P; Touraine R
    Poumon Coeur; 1982; 38(1):57-62. PubMed ID: 6283505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF.
    Meldgaard Knudsen L; Jensen L; Gaarsdal E; Nikolaisen K; Johnsen HE
    Bone Marrow Transplant; 2000 Oct; 26(7):717-22. PubMed ID: 11042651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EST 0469B--comparison of high- and low-dose cyclophosphamide in human lung cancer.
    Hall TC; Pocock S; Brodovsky H; Horton J; Shnider BI; Colsky J; Oberfield RA
    Med Pediatr Oncol; 1978; 5(1):231-40. PubMed ID: 370535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment with cone moxibustion of chemotherapeutic leukocytopenia in 114 cases.
    Huang X; Chen H; Guo X; Ma Y
    J Tradit Chin Med; 1993 Dec; 13(4):266-7. PubMed ID: 8139276
    [No Abstract]   [Full Text] [Related]  

  • 53. Zusanli point injection for treating leukopenia induced by radio-chemotherapy.
    Xie L; Zhao L; Li M
    J Tradit Chin Med; 2003 Mar; 23(1):59-61. PubMed ID: 12747206
    [No Abstract]   [Full Text] [Related]  

  • 54. [Regression of lung carcinoma metastsis caused by use of endoxan].
    Zivkov A; Mincev PB
    God Zb Med Fak Skopje; 1975; 21():161-7. PubMed ID: 1213518
    [No Abstract]   [Full Text] [Related]  

  • 55. [The problem of leukopenia as a side-effect of intravenous long-term therapy of malignant tumors and leukoses with endoxan].
    FRITZSCHE D; RIETSCHEL HG
    Med Klin; 1962 Aug; 57():1485-9. PubMed ID: 13959916
    [No Abstract]   [Full Text] [Related]  

  • 56. [Studies on the administration of massive doses of endoxan in pulmonary neoplasms].
    Górecki R; Brodziak R; Gondorowicz K; Stanek S
    Gruzlica; 1969 Mar; 37(3):251-4. PubMed ID: 4182112
    [No Abstract]   [Full Text] [Related]  

  • 57. [Chemotherapy of malignant tumors using massive-dose administration of Endoxan].
    Pigatto JC
    Munch Med Wochenschr; 1967 Oct; 109(40):2082-4. PubMed ID: 4873942
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of lung cancer with Endoxan, with reference to the effect of massive intermittent administration].
    Matsuda M; Nishihara H; Komatsu T; Hattori S; Terasawa T
    Saishin Igaku; 1967 Aug; 22(8):1808-20. PubMed ID: 6081168
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of large single doses of cyclophosphane (endoxan)].
    Garin AM
    Vopr Onkol; 1970; 16(11):43-8. PubMed ID: 4929048
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment with large doses of Endoxan].
    Araujo E; Estevez R; Sanchez Suarez R; Chacon R; Gonzalez G
    Med Monatsschr; 1967 Aug; 21(8):371-3. PubMed ID: 5597100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.